As part of our holistic approach, SFL provides specialized training courses where participants can benefit from our team’s cross-functional expertise and learn about the basis and latest developments in Regulatory affairs, Devices and combination products, Quality assurance, Reimbursement, Supply chain and Medical communications.
Our training courses have been approved by the SwAPP (Swiss Association of Pharmaceutical Professionals) Commission for Professional Development and SGPM (Swiss Society of Pharmaceutical Medicine). All participants will receive credits upon completion of the SFL training course.
Members of Medtech & Pharma Platform (MPP), Swiss Association of Pharmaceutical Professionals (SwAPP) and Swiss Biotech Association (SBA) will benefit from fee reduction.
Information on our upcoming trainings will be published on this website. Follow us on Twitter or on LinkedIn to be informed about our next trainings.
Strategic regulatory considerations for global drug development (3 November 2021, 3:00-6:00pm │Registration)
Participants in the training will receive 3 SwAPP credits.